DSM421

CAS No. 2011769-21-2

DSM421( —— )

Catalog No. M34228 CAS No. 2011769-21-2

DSM421 (DSM-421) is a dihydrodehydrogenase inhibitor (DHODH) that is in preclinical development as a potential treatment option for malaria and has shown activity against field isolates of both P. falciparum and P. vivax.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 318 In Stock
5MG 273 In Stock
10MG 372 In Stock
25MG 563 In Stock
50MG 742 In Stock
100MG 977 In Stock
200MG 1293 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    DSM421
  • Note
    Research use only, not for human use.
  • Brief Description
    DSM421 (DSM-421) is a dihydrodehydrogenase inhibitor (DHODH) that is in preclinical development as a potential treatment option for malaria and has shown activity against field isolates of both P. falciparum and P. vivax.
  • Description
    DSM421 (DSM-421) is a dihydrodehydrogenase inhibitor (DHODH) that is in preclinical development as a potential treatment option for malaria and has shown activity against field isolates of both P. falciparum and P. vivax.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Dehydrogenase
  • Recptor
    Dehydrogenase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2011769-21-2
  • Formula Weight
    358.27
  • Molecular Formula
    C14H11F5N6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N(C=1N2C(=NC(C(C)(F)F)=N2)N=C(C)C1)C=3C=CC(C(F)(F)F)=NC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Endothall

    The monohydrate is in the form of colorless crystals. Non corrosive. Used as a selective herbicide.

  • Trilostane

    Trilostane is an inhibitor of 3 beta-hydroxysteroid dehydrogenase used in the treatment of Cushing's syndrome.

  • Skepinone-L

    Skepinone-L is a selective p38 mitogen-activated protein kinase inhibitor.